Insulet Corp (PODD)

$163.72 -3.65 (-2.18%)
Market Cap 11.36B
Revenue (ttm) 2.71B
Net Income (ttm) 247.10M
EPS (ttm) N/A
PE Ratio 30.56
Forward PE 25.48
Profit Margin 9.12%
Debt to Equity Ratio 0.73
Volume 1,145,400
Avg Vol 1,563,722
Day's Range N/A - N/A
Shares Out 69.27M
Stochastic %K 85%
Beta 1.11
Analysts Strong Sell
Price Target $229.64

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
bulltrades1234
bulltrades1234 Jul. 21 at 6:59 PM
$PODD when $250 podd
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Jul. 21 at 3:29 PM
$MODD my brother, not a single insulin pump stock is up right now Its a bear market for pumps $PODD $MDT $TNDM $BBNX $ROCHE Literally the only excpwtion is ypsomed, which does more than just pumps. Pop an oxy and vibrate for a minute. You are concerned over nothing. Hold 💎✊️
0 · Reply
OnlyFibs
OnlyFibs Jul. 21 at 1:55 AM
As a medical device leader scaling its global Omnipod ecosystem and advanced automated insulin delivery algorithms, $PODD combines robust earnings performance with expanding operating margins. The 8 hour chart shows the stock consolidating cleanly near $167.30 as institutional accumulation builds. 🐂🎯 Bull Key Levels: Need to see a clean push through $172.00 to ignite fresh buying volume and trap late short sellers. 🐂🔥 Bear Key Levels: If the $160.00 level fails to hold, expect the price to consolidate further within the broader channel range. 🐻⚠️ Take Profit Targets: $184.00 / $198.00. 💰💸 #hovdid #podd #medtech #stocks #investing
1 · Reply
bulltrades1234
bulltrades1234 Jul. 20 at 8:12 PM
$PODD looks like on an upward trajectory now
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Jul. 20 at 6:07 PM
$MODD Gonna eat these guys lunch one day, then pump myself with the Pivot5 to compensate for their disgusting carb loaded diet. Bench a quick 300 lbs. Do it again, then offer a firm a shake just to transition it into an L on my forehead. $PODD $MDT $TNDM
1 · Reply
k3vl4r
k3vl4r Jul. 18 at 11:12 AM
I was scanning the charts and caught a bump on $PODD. This diabetes device franchise is cruising on 71% gross margins, 23% ROE, and 32% TTM sales growth, sales have dropped about half YTD but I see an opportunity. Check out my forecast, price targets, and multi-horizon plan: https://app.k3vl4r.com/r/podd-ai-stock-forecast-0ea09f46b316175c043de16dc1787395?utm_source=x&utm_medium=social&utm_campaign=report_drop&utm_content=PODD #stocks #trading
0 · Reply
k3vl4r
k3vl4r Jul. 17 at 10:28 AM
Good morning traders. Not a bad week so far on our auto picks. Let's wrap the week up strong. If you want to follow along with our picks they will be live at 8am ET at https://app.k3vl4r.com/picks $TMDX $PODD $TRMB $INTU
0 · Reply
UNCPETE
UNCPETE Jul. 16 at 2:41 PM
$PODD Yes
0 · Reply
UNCPETE
UNCPETE Jul. 16 at 1:56 PM
$PODD Just bought 15 shares. Long.
1 · Reply
RocketTrader11
RocketTrader11 Jul. 15 at 3:49 PM
$PODD https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-receives-research-demonstrating-positive-payor-recept-1190677
0 · Reply
Latest News on PODD
Insulet partners with Calm to provide resources for people living with diabetes

2026-07-14T09:30:09.000Z - 7 days ago

Insulet partners with Calm to provide resources for people living with diabetes

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

Jul 14, 2026, 3:00 AM EDT - 7 days ago

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

Jul 13, 2026, 5:14 PM EDT - 8 days ago

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

Insulet price target lowered to $210 from $219 at Truist

2026-07-13T13:50:42.000Z - 8 days ago

Insulet price target lowered to $210 from $219 at Truist

Insulet price target lowered to $245 from $280 at RBC Capital

2026-07-13T13:20:52.000Z - 8 days ago

Insulet price target lowered to $245 from $280 at RBC Capital

TNDM

Insulet price target lowered to $225 from $250 at Stifel

2026-07-10T11:20:25.000Z - 11 days ago

Insulet price target lowered to $225 from $250 at Stifel

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Jul 9, 2026, 1:32 PM EDT - 12 days ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Insulet price target raised to $172 from $165 at Citi

2026-07-08T10:41:16.000Z - 13 days ago

Insulet price target raised to $172 from $165 at Citi

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jul 6, 2026, 12:04 PM EDT - 15 days ago

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Insulet price target lowered to $180 from $200 at Evercore ISI

2026-07-06T12:51:13.000Z - 15 days ago

Insulet price target lowered to $180 from $200 at Evercore ISI

Insulet announces launch of Omipod 5, Omnipod Discover in Spain

2026-07-06T11:05:18.000Z - 15 days ago

Insulet announces launch of Omipod 5, Omnipod Discover in Spain

Insulet Slides: Investor presentation

Jul 6, 2026, 7:00 AM EDT - 15 days ago

Insulet Slides: Investor presentation

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

Jul 3, 2026, 1:31 PM EDT - 18 days ago

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

FDA says Insulet recalled certain Omnipod Pods

2026-07-02T17:35:40.000Z - 19 days ago

FDA says Insulet recalled certain Omnipod Pods

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Jul 1, 2026, 7:00 AM EDT - 20 days ago

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

20 stocks in the S&P 500 that plunged the most in 2026's first half

Jun 30, 2026, 7:55 AM EDT - 21 days ago

20 stocks in the S&P 500 that plunged the most in 2026's first half

ACN ADBE BR BSX CRM CSGP CTSH

Insulet appoints Mazelsky to its Board of Directors

2026-06-25T11:05:30.000Z - 26 days ago

Insulet appoints Mazelsky to its Board of Directors

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Jun 25, 2026, 7:00 AM EDT - 26 days ago

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Insulet initiated with a Buy at Deutsche Bank

2026-06-23T16:57:56.000Z - 4 weeks ago

Insulet initiated with a Buy at Deutsche Bank

Insulet initiated with a Buy at Deutsche Bank

2026-06-23T13:18:30.000Z - 4 weeks ago

Insulet initiated with a Buy at Deutsche Bank

Insulet price target lowered to $219 from $250 at Truist

2026-06-11T17:35:58.000Z - 5 weeks ago

Insulet price target lowered to $219 from $250 at Truist

Insulet price target lowered to $216 from $263 at Raymond James

2026-06-08T19:25:55.000Z - 6 weeks ago

Insulet price target lowered to $216 from $263 at Raymond James

Insulet announces new results on tubeless AID systems

2026-06-07T21:55:05.000Z - 6 weeks ago

Insulet announces new results on tubeless AID systems

CDRH issues Early Alert about pump issue from Insulet

2026-06-04T18:35:28.000Z - 6 weeks ago

CDRH issues Early Alert about pump issue from Insulet

Insulet announces planned activities during ADA Scientific Sessions

2026-06-04T11:08:57.000Z - 6 weeks ago

Insulet announces planned activities during ADA Scientific Sessions

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Jun 4, 2026, 7:00 AM EDT - 6 weeks ago

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 6 weeks ago

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 6 weeks ago

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Insulet announces U.S. rollout of enhanced Omnipod 5 algorithm

2026-06-03T11:35:31.000Z - 6 weeks ago

Insulet announces U.S. rollout of enhanced Omnipod 5 algorithm

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

Jun 3, 2026, 7:00 AM EDT - 6 weeks ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

May 28, 2026, 10:34 AM EDT - 7 weeks ago

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

May 27, 2026, 4:05 PM EDT - 7 weeks ago

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

May 26, 2026, 4:50 PM EDT - 2 months ago

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 26, 2026, 4:05 PM EDT - 2 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

May 20, 2026, 10:05 AM EDT - 2 months ago

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

APH APP AXON CSGP CVNA EL FICO

Insulet Transcript: AGM 2026

May 20, 2026, 8:00 AM EDT - 2 months ago

Insulet Transcript: AGM 2026

Insulet Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 12:20 PM EDT - 2 months ago

Insulet Transcript: Bank of America Global Healthcare Conference 2026

Insulet Slides: FY 2026

May 13, 2026, 12:20 PM EDT - 2 months ago

Insulet Slides: FY 2026

Insulet Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Earnings Call Transcript: Q1 2026

Insulet Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Earnings release: Q1 2026

Insulet Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Slides: Q1 2026

Insulet Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Quarterly report: Q1 2026

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

May 6, 2026, 7:46 AM EDT - 2 months ago

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

Insulet Reports First Quarter 2026 Results

May 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Reports First Quarter 2026 Results

Insulet Slides: Investor presentation

May 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Investor presentation

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026, 7:00 AM EDT - 2 months ago

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

May 5, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

May 4, 2026, 7:00 AM EDT - 2 months ago

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

Insulet to Participate in BofA Securities 2026 Health Care Conference

Apr 28, 2026, 7:00 AM EDT - 3 months ago

Insulet to Participate in BofA Securities 2026 Health Care Conference

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Proxy statement: Proxy filing

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Proxy statement: Proxy filing

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Apr 1, 2026, 7:00 AM EDT - 3 months ago

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Appoints Mike Panos as Chief Commercial Officer

Mar 30, 2026, 8:30 AM EDT - 4 months ago

Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet recalls some insulin devices in US over leakage risk

Mar 12, 2026, 5:22 PM EDT - 4 months ago

Insulet recalls some insulin devices in US over leakage risk

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Mar 12, 2026, 4:05 PM EDT - 4 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Mar 11, 2026, 4:01 PM EDT - 4 months ago

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Mar 10, 2026, 7:00 AM EDT - 4 months ago

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 5 months ago

Insulet Earnings Call Transcript: Q4 2025

Insulet Annual report: Q4 2025

Feb 18, 2026, 8:00 AM EST - 5 months ago

Insulet Annual report: Q4 2025

Insulet Earnings release: Q4 2025

Feb 18, 2026, 8:00 AM EST - 5 months ago

Insulet Earnings release: Q4 2025

Insulet Slides: Q4 2025

Feb 18, 2026, 8:00 AM EST - 5 months ago

Insulet Slides: Q4 2025

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:55 AM EST - 5 months ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 18, 2026, 7:00 AM EST - 5 months ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Insulet Slides: Investor presentation

Feb 18, 2026, 7:00 AM EST - 5 months ago

Insulet Slides: Investor presentation

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Feb 5, 2026, 7:00 AM EST - 5 months ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Is PODD A Better Bet Than ISRG Stock?

Jan 19, 2026, 12:41 PM EST - 6 months ago

Is PODD A Better Bet Than ISRG Stock?

ISRG

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 6 months ago

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 6 months ago

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Jan 9, 2026, 6:00 AM EST - 6 months ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Jan 6, 2026, 7:00 AM EST - 7 months ago

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 7:00 AM EST - 7 months ago

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Dec 15, 2025, 7:00 AM EST - 7 months ago

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Eight stock picks to play one of the healthiest corners of the market

Dec 11, 2025, 10:37 AM EST - 7 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA UNH WGS

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Dec 4, 2025, 7:00 AM EST - 8 months ago

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Nov 20, 2025, 12:30 PM EST - 8 months ago

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Insulet Transcript: Investor Day 2025

Nov 20, 2025, 9:00 AM EST - 8 months ago

Insulet Transcript: Investor Day 2025

Insulet Slides: FY 2025

Nov 20, 2025, 9:00 AM EST - 8 months ago

Insulet Slides: FY 2025

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

Nov 12, 2025, 2:15 PM EST - 8 months ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG

Insulet Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Insulet Earnings Call Transcript: Q3 2025

Insulet Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Insulet Quarterly report: Q3 2025

Insulet Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Insulet Earnings release: Q3 2025

Insulet Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Insulet Slides: Q3 2025

Insulet tops quarterly estimates on demand for wearable insulin pumps

Nov 6, 2025, 7:29 AM EST - 9 months ago

Insulet tops quarterly estimates on demand for wearable insulin pumps

Insulet Reports Third Quarter 2025 Results

Nov 6, 2025, 6:30 AM EST - 9 months ago

Insulet Reports Third Quarter 2025 Results

Final Trades: Insulet Corp, Uber and Apollo Global

Nov 4, 2025, 1:20 PM EST - 9 months ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER

bulltrades1234
bulltrades1234 Jul. 21 at 6:59 PM
$PODD when $250 podd
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Jul. 21 at 3:29 PM
$MODD my brother, not a single insulin pump stock is up right now Its a bear market for pumps $PODD $MDT $TNDM $BBNX $ROCHE Literally the only excpwtion is ypsomed, which does more than just pumps. Pop an oxy and vibrate for a minute. You are concerned over nothing. Hold 💎✊️
0 · Reply
OnlyFibs
OnlyFibs Jul. 21 at 1:55 AM
As a medical device leader scaling its global Omnipod ecosystem and advanced automated insulin delivery algorithms, $PODD combines robust earnings performance with expanding operating margins. The 8 hour chart shows the stock consolidating cleanly near $167.30 as institutional accumulation builds. 🐂🎯 Bull Key Levels: Need to see a clean push through $172.00 to ignite fresh buying volume and trap late short sellers. 🐂🔥 Bear Key Levels: If the $160.00 level fails to hold, expect the price to consolidate further within the broader channel range. 🐻⚠️ Take Profit Targets: $184.00 / $198.00. 💰💸 #hovdid #podd #medtech #stocks #investing
1 · Reply
bulltrades1234
bulltrades1234 Jul. 20 at 8:12 PM
$PODD looks like on an upward trajectory now
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Jul. 20 at 6:07 PM
$MODD Gonna eat these guys lunch one day, then pump myself with the Pivot5 to compensate for their disgusting carb loaded diet. Bench a quick 300 lbs. Do it again, then offer a firm a shake just to transition it into an L on my forehead. $PODD $MDT $TNDM
1 · Reply
k3vl4r
k3vl4r Jul. 18 at 11:12 AM
I was scanning the charts and caught a bump on $PODD. This diabetes device franchise is cruising on 71% gross margins, 23% ROE, and 32% TTM sales growth, sales have dropped about half YTD but I see an opportunity. Check out my forecast, price targets, and multi-horizon plan: https://app.k3vl4r.com/r/podd-ai-stock-forecast-0ea09f46b316175c043de16dc1787395?utm_source=x&utm_medium=social&utm_campaign=report_drop&utm_content=PODD #stocks #trading
0 · Reply
k3vl4r
k3vl4r Jul. 17 at 10:28 AM
Good morning traders. Not a bad week so far on our auto picks. Let's wrap the week up strong. If you want to follow along with our picks they will be live at 8am ET at https://app.k3vl4r.com/picks $TMDX $PODD $TRMB $INTU
0 · Reply
UNCPETE
UNCPETE Jul. 16 at 2:41 PM
$PODD Yes
0 · Reply
UNCPETE
UNCPETE Jul. 16 at 1:56 PM
$PODD Just bought 15 shares. Long.
1 · Reply
RocketTrader11
RocketTrader11 Jul. 15 at 3:49 PM
$PODD https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-receives-research-demonstrating-positive-payor-recept-1190677
0 · Reply
jheerdink
jheerdink Jul. 15 at 2:12 PM
$PODD 97% https://vistapglobal.com/the-97-signal-why-millions-of-diabetes-patients-are-ready-to-ditch-the-needle-and-what-one-company-is-doing-about-it-modd-mdt-podd-tndm/
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Jul. 14 at 2:52 PM
$PODD just buy Modular Medicals Pivot device wtf are you even doing
1 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Jul. 14 at 2:50 PM
$MODD ✊️💎📈 $PODD $TNDM $MDT Feeling nervous yet?
0 · Reply
Dr_Stoxx
Dr_Stoxx Jul. 14 at 2:00 PM
$PODD: dip and test of 50sma just now. I've mentioned this one before as a "bullish base breakout". Indicators support the move but price has been musted. I have a nibble...prolly not official but just putting it out there.
1 · Reply
RocketTrader11
RocketTrader11 Jul. 14 at 1:56 PM
$PODD https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-announces-completion-of-research-initiative-indicatin-1189761
1 · Reply
k3vl4r
k3vl4r Jul. 10 at 10:09 PM
I’ve been watching $PODD lately. The franchise is rocking 71% gross margins, 23% ROE, and 32% TTM sales growth. After a YTD drop to roughly $161, I see upside in the forecasted price targets and a multi-horizon plan that doesn’t ignore the downside risk. Check out the details here: https://app.k3vl4r.com/r/podd-ai-stock-forecast-7a0d8c11911ed21946d310ca0cfa2d95?utm_source=x&utm_medium=social&utm_campaign=report_drop&utm_content=PODD #stocks #trading
0 · Reply
jjjetplane
jjjetplane Jul. 10 at 7:28 PM
Doubled $MSFT and $NVDA positions today. Started $PODD and $RMD
0 · Reply
IN0V8
IN0V8 Jul. 10 at 2:53 PM
$PODD Opportunity Stifel cuts target price to $225 from $250
1 · Reply
JInvestTrade
JInvestTrade Jul. 9 at 4:00 PM
$SENS $DXCM $TNDM $ABT $PODD https://lnkd.in/p/gTqmQHT6
1 · Reply
Dr_Stoxx
Dr_Stoxx Jul. 8 at 5:51 PM
$PODD
1 · Reply
Dr_Stoxx
Dr_Stoxx Jul. 8 at 5:50 PM
$PODD: one for your value port. In the strong med-tech space, very profitable, strong growth, and now printing a bullish base breakout. I looked at calls for the Options Room but spreads are too wide. Not official, but I just bought some shares for a longer hold. 153/176.
0 · Reply
IN0V8
IN0V8 Jul. 8 at 3:04 PM
$PODD Buy Citigroup raises target price to $172 from $165
0 · Reply